INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹604 Cr | ₹422 Cr | ₹205 Cr | ₹157 Cr | ₹158 Cr |
What is the latest Total Non-Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹604 Cr |
| Mar2024 | ₹422 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹157 Cr |
| Mar2021 | ₹158 Cr |
How is Total Non-Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹604 Cr | 43.05 | |
| Mar2024 | ₹422 Cr | 105.37 | |
| Mar2023 | ₹205 Cr | 31.19 | |
| Mar2022 | ₹157 Cr | -1.12 | |
| Mar2021 | ₹158 Cr | - | |
Compare Total Non-Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,750.0 Cr | -3.4% | -7.7% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -3.4% |
-7.7% |
-15.3% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses